Disc Medicine annual operating cash flow
2020
2021
2022
2023
2024
2025
Disc Medicine Operating Cash Flow Growth & History (IRON)
Disc Medicine's operating cash flow was −$180.4M for fiscal 2025.
View full Disc Medicine company overviewDisc Medicine annual operating cash flow history
| Fiscal year | Period ended | Operating cash flow | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$180.4M | −$86.5M | — |
| 2024 | 2024-12-31 | −$93.9M | −$20.5M | — |
| 2023 | 2023-12-31 | −$73.5M | −$31.2M | — |
| 2022 | 2022-12-31 | −$42.3M | −$14.7M | — |
| 2021 | 2021-12-31 | −$27.5M | $5.2M | — |
| 2020 | 2020-12-31 | −$32.7M | — | — |
Disc Medicine quarterly operating cash flow
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating cash flow | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$44.2M | $3.7M | — |
| Q1 2026 | 2026-03-31 | −$62.2M | −$20.9M | — |
| Q4 2025 | 2025-12-31 | −$43.3M | −$15.7M | — |
| Q3 2025 | 2025-09-30 | −$47.8M | −$30.4M | — |
| Q2 2025 | 2025-06-30 | −$47.9M | −$32.5M | — |
| Q1 2025 | 2025-03-31 | −$41.4M | −$7.8M | — |
| Q4 2024 | 2024-12-31 | −$27.6M | −$9.8M | — |
| Q3 2024 | 2024-09-30 | −$17.4M | −$9.9M | — |
| Q2 2024 | 2024-06-30 | −$15.4M | −$2.7M | — |
| Q1 2024 | 2024-03-31 | −$33.6M | $1.9M | — |
| Q4 2023 | 2023-12-31 | −$17.8M | −$8.1M | — |
| Q3 2023 | 2023-09-30 | −$7.5M | $2.2M | — |
| Q2 2023 | 2023-06-30 | −$12.7M | −$3.5M | — |
| Q1 2023 | 2023-03-31 | −$35.5M | −$21.8M | — |
| Q4 2022 | 2022-12-31 | −$9.7M | −$29.2M | — |
| Q3 2022 | 2022-09-30 | −$9.7M | $6.4M | — |
| Q2 2022 | 2022-06-30 | −$9.2M | $6.7M | — |
| Q1 2022 | 2022-03-31 | −$13.7M | $1.3M | — |
| Q4 2021 | 2021-12-31 | $19.5M | $35.1M | — |
| Q3 2021 | 2021-09-30 | −$16.1M | −$15.9M | — |
| Q2 2021 | 2021-06-30 | −$15.9M | −$8.9M | — |
| Q1 2021 | 2021-03-31 | −$15.0M | −$5.1M | — |
| Q4 2020 | 2020-12-31 | −$15.6M | — | — |
| Q3 2020 | 2020-09-30 | −$190,568 | — | — |
| Q2 2020 | 2020-06-30 | −$7.0M | — | — |
| Q1 2020 | 2020-03-31 | −$9.9M | — | — |
Disc Medicine operating cash flow trends
Over the last five fiscal years, Disc Medicine's operating cash flow decreased from −$32.7M to −$180.4M, a change of −$147.7M. The latest reported quarter, Q2 2026, shows −$44.2M.
About the metric
What operating cash flow means
Operating cash flow is the cash generated or used by a company’s core operations. It incorporates working-capital movements and other operating cash items, and it is the starting point for calculating free cash flow.
Calculation and source
SEC-reported operating cash flow
TickerStat standardizes net cash provided by or used in operating activities reported in company SEC filings. It is historical filing data before capital expenditures, financing activities, and investing activities. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Disc Medicine source filings ↗Community posts
Disc Medicine prices an enlarged $450 million equity offering
Disc Medicine ($IRON) priced an upsized public offering of six million common shares at $75 each, generating expected gross proceeds of $450 million before underwriting discounts and expenses. Underwriters have a 30-day option to buy anothe ...
